Differential Expression Profiles of Plasma Exosomal microRNAs in Rheumatoid Arthritis
Xiaoke Yang,Zhixin Wang,Mingming Zhang,Zongwen Shuai
DOI: https://doi.org/10.2147/jir.s413994
IF: 4.5
2023-08-28
Journal of Inflammation Research
Abstract:Xiaoke Yang, &ast Zhixin Wang, &ast Mingming Zhang, Zongwen Shuai Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zongwen Shuai, Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China, Tel +86 551 62922247, Fax +86 551 62923040, Email Aim: Differential expression maps of microRNAs (miRNAs) are connected to the autoimmune diseases. This study sought to elucidate the expression maps of exosomal miRNA in plasma of rheumatoid arthritis (RA) patients and their potential clinical significance. Methods: In the screening phase, small RNA sequencing was performed to characterize dysregulated exosome-derived miRNAs in the plasma samples from six patients with RA and six healthy patients. At the independent verification stage, the candidate plasma exosomal miRNAs were verified in 40 patients with RA and 32 healthy patients by using qRT-PCR. The correlation of miRNA levels and clinical characteristics was tested in patients with RA. The value of these miRNAs in diagnosing RA was assessed with the receiver operating characteristic curve. Results: During the screening phase, 177 and 129 miRNAs were increased and decreased in RA patients and healthy controls, respectively. There were 10 candidate plasma exosomal miRNAs selected for the next identification. Compared with the healthy controls, eight plasma exosomal miRNAs (let-7a-5p, let-7b-5p, let-7d-5p, let-7f-5p, let-7g-5p, let-7i-5p, miR-128-3p, and miR-25-3p) were significantly elevated in RA patients, but miR-144-3p and miR-15a-5p expression exhibited no significant changes. The let-7a-5p and miR-25-3p levels were linked to the rheumatoid factor-positive phenotype in RA patients. For the eight miRNAs, the area under the subject work characteristic curve (AUC) is 0.641 to 0.843, and their combination had a high diagnostic accuracy for RA (AUC = 0.916). Conclusion: Our study illustrates that novel exosomal miRNAs in the plasma may represent potential noninvasive biomarkers for RA. Keywords: rheumatoid arthritis, plasma exosome, microRNAs, biomarker, small RNA sequencing Rheumatoid arthritis (RA) belongs to the autoimmune disease that exhibits chronic systemic symptoms that primarily impair cartilage and bone, leading to joint swelling, pain, impaired movement, and decreased quality of life. 1 Approximately 0.5–1.0% of the population are affected by RA worldwide, disproportionately affecting females at a 3:1 ratio to males. 2,3 It has been proved that genetic, epigenetic and environmental factors were involved in RA development. 4 Many genes have been found to be related to RA susceptibility via genome-wide association studies. Over 80% of the human genome is transcribed with little or no protein-coding capability. 5 It was reported that microRNAs (miRNAs) played a key role in the development and progression of autoimmune diseases such as RA, and circulating levels of miRNA may represent potential biomarkers for these diseases. 6,7 Cells could secret various extracellular vesicles, including exosomes, and are ubiquitously distributed in bodily fluids. 8,9 With the characteristics of stability and biocompatibility, exosomes play essential roles in autoimmune diseases. 10 Moreover, exosomes can also serve as carriers through which to contain and deliver a variety of functional substances to assist in intercellular communications. 11–13 MiRNAs are defined as single-stranded noncoding RNAs consisting of ~22 nucleotides that participate in regulating post-transcriptional gene expression. 14 Therefore, utilizing RNA sequence technology, growing evidence indicates that dysregulated exosomal miRNAs were promising biomarkers for diagnosis and treatment of tumor and autoimmune diseases. 15–19 However, there are limited studies investigating the differential expression profiles of miRNAs derived from plasma exosomes in RA. Exosomes that could be released by various cells have been reported, including inflammatory and immune cells responsible for RA development. 20 Growing results suggest that miRNAs contained in exosomes are critically involved in inflammation and immunity. 21 Therefore, it is important to identify additional dysregulated miRNAs as novel biomarkers and potential targets for RA therapy. Herein, we investigated expression maps of exosomal miRNAs in plasma of patients with RA versus healthy controls, and analyzed their potential clinical significance. A two-stage analysis was co -Abstract Truncated-
immunology